-
British PM says to make 'difficult decisions' as inflation rises
-
Watts, Pitt, Cruz to light up Spain's top film festival
-
TotalEnergies pumps up controversy in France with cut-price gas
-
Sweden expels Iran embassy employee over anti-Jewish threats
-
Global fuel price demos: a round-up
-
Toogood Gold's Table Mountain Sits in the Shadow of a Nevada Gold Rush
-
Leverate Launches MCP for Traders to Connect AI Assistants With Trading Platforms
-
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
-
MEXC Launches $1M "Discover Your Wall Street DNA" Campaign to Help Traders Find Their Market Fit
-
'Breathing toxin every day': Indonesians choked by haze feel helpless
-
Emporio Armani names Dario Vitale new creative director
-
Stocks edge higher ahead of US Fed rate call
-
Maresca defends VAR officials after Man City benefit from error
-
Philippines ex-leader Duterte makes first in-person ICC appearance
-
Courts jails LGBTQ activists as Turkey crackdown widens
-
2027 Formula One calendar includes Monaco sprint race
-
French court to hear Depardieu's appeal against rape trial order: sources
-
Palestinians are the real victims, Thunberg tells Ed Sheeran
-
The German state premier hoping to halt far-right surge
-
Hashim Thaci: From 'George Washington of Kosovo' to Hague convict
-
Lebanon wants Israel security deal as prelude to peace: president to AFP
-
Amnesty says Iran committed 'crimes against humanity' in crackdown on 2022 protests
-
England's Brook keen to learn from 'hero' Pietersen after stunning ton
-
EU to ban social media for under 13s, curb access until 15
-
Saudi says Houthis target Mecca, warns of 'red line'
-
Philippines ex-leader Duterte makes first appearance at ICC
-
Phillippines ex-leader Duterte makes first appearance at ICC
-
EU chief pitches 'associate member' status for Canada
-
Lebanon wants Israel security deal, Hezbollah disarmament without confrontation: president to AFP
-
English village votes to 'secede' from UK over asylum centre plan
-
BASIS.pro Expands On-Chain Infrastructure with XDC Network Partnership and Zypher DAO as Auto Earn Goes Live
-
Wildfires push endangered Sumatran elephants to brink: Indonesian NGO
-
Samson relishing battle with teen star Sooryavanshi for India spot
-
Stocks head higher as traders prepare for Fed decision
-
Pickle-flavoured tart? AI inspires Japan's convenience stores
-
English village votes to 'secede' from UK over asylum centre
-
Macau holds first closed-door national security trial
-
Hong Kong unveils plan to align economy with China's goals
-
Bank of Japan set to raise rates under pressure from inflation, US
-
Brazilian voters the latest to eye Bukele security model with envy
-
Zverev, Shelton back on court for Davis Cup qualifiers
-
EU chief hosts Canada's Carney in push to 'deepen' alliance
-
Peace is a 'dangerous' word in Russian city heading to polls
-
EU chief to unveil social media, gaming curbs for under-15s
-
Meta chief pushes back on AI slowdown calls
-
Saudi says Houthis target Mecca, warn of 'red line'
-
'Resident Evil' film brings video game's ethos to the big screen
-
Asian stocks stutter as traders prepare for Fed decision
-
Court orders N. Korea pay Seoul $32.5 mn for blowing up office
-
US touts its power, avoids Iran war at G20 Energy meeting
Texas federal judge halts US approval of abortion pill
A conservative federal judge in the state of Texas halted US approval of the abortion pill mifepristone on Friday, but paused implementation for a week to give federal authorities time to appeal.
The suit against the Food and Drug Administration is the latest step in the campaign to win a total ban on abortion following a landmark Supreme Court ruling last year. It takes aim at a pill involved in 53 percent of all abortions in the United States, or more than half a million every year.
"FDA's approval of mifepristone is hereby STAYED," Judge Matthew Kacsmaryk wrote in his decision, adding that the court was also halting "applicability of this opinion and order for seven (7) days."
While the FDA has never been challenged like this before on its approval of a drug that has proven safe and effective, the plaintiffs -- a coalition of anti-abortion groups -- counted on being able to win a national freeze on distribution of mifepristone.
Presiding over the case in federal court in Amarillo, Texas is Kacsmaryk, who was appointed to the bench by Republican former president Donald Trump and confirmed by the Senate in 2019.
The judge is a conservative Christian with a personal history of opposition to abortion and a court record of favoring right-wing causes.
The case landed in his court via what critics call "judge-shopping," in which plaintiffs take legal action in a district where the judge has a history of rulings that support their case.
Federal judges in the United States have a right to issue rulings that carry national legal force.
Democratic politicians were quick to react on social media.
"This ruling opens a new door to politicizing medicine," New York Governor Kathy Hochul posted on Twitter. "Extremists will not stop at stripping away abortion rights."
Massachusetts Senator Elizabeth Warren posted that "because of today's lawless ruling, women could lose access to a safe and legal medication they've relied on for decades."
One component of a two-drug regimen used for medication abortion, mifepristone can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
While abortion care has halted in more than a dozen states after the Supreme Court overturned the long-established constitutional right last June, it is still legal in dozens more.
O.Brown--AT